In breast cancer patients, a high amount of TGFβ released by tumor cells, combined with sustained TCR-stimulation, increases the acquired expression of FOXP3 in CD4+CD25- T cells, allowing them to develop into Treg cells. The gene discussed is CD4; the disease is neoplasm.